SNIPR Biome, the pioneering company at the forefront of microbiome research and gene therapy, has successfully raised an impressive $149 million in its latest funding round aimed at advancing its groundbreaking CRISPR-based technologies. Known for its revolutionary approach to precision killing of bacteria, SNIPR Biome’s innovative methodologies are poised to transform the management of untreatable infections and complex diseases intricately linked to the human microbiota. This significant investment will be instrumental in accelerating the company's ambitious mission to develop effective and safe gene therapies that address a spectrum of difficult-to-treat conditions, providing hope to patients who currently have limited treatment options. With this new capital, SNIPR Biome plans to enhance its research capabilities and expedite clinical trials for its lead therapies, which target harmful bacterial strains while preserving beneficial ones. As the company forges ahead, it is set to play a critical role in the evolution of microbiome-centric medicine, contributing to an era where precision treatments can significantly improve health outcomes. With an experienced team of scientists and a robust intellectual property portfolio, SNIPR Biome is well-equipped to make landmark strides in therapeutic innovation, ultimately seeking to offer tailored solutions that empower healthcare providers and enhance patient care. This funding marks not just a financial milestone for SNIPR Biome but also a crucial step toward a future where the complexities of the human microbiome can be adeptly harnessed to improve lives worldwide.
Revolutionizing Microbiome Medicine: SNIPR Biome Secures $149M Funding for CRISPR-Based Therapies
Recently funded · $149.0MBiotechnology
Get the full SNIPR Biome company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
